Screener
Sionna Therapeutics SION Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Sionna Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
FAQ
- What is Sionna Therapeutics's debt-to-equity?
- Sionna Therapeutics (SION) reported debt-to-equity of 0× in Q1 2026.
- How has Sionna Therapeutics's debt-to-equity changed year-over-year?
- Sionna Therapeutics's debt-to-equity increased by 7.8% year-over-year, from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Sionna Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude